CD44 and urinary bladder carcinoma: Self-assembled tumor-targeting HA–IR–780 nanoparticles (HA MW = 10 kDa, and the average size was 171.3 ± 9.14 nm) for PTT in a CD44-over-expressed orthotopic bladder cancer model (MB-49 bladder cancer cells were used) have been developed [90].